News|Videos|November 19, 2026

Phage-Embedded Bacterial Cellulose Dressing Targets Chronic Wound Biofilms

In early in vitro testing, a bacterial cellulose dressing loaded with bacteriophages reduced S aureus and P aeruginosa biofilms, and optimized versions reached 70% to 90% reductions.

A wound dressing made of bacterial cellulose embedded with bacteriophages reduced Staphylococcus aureus and Pseudomonas aeruginosa biofilms in early in vitro testing, according to Anna Żywicka, PhD, of the Department of Microbiology and Biotechnology and the Nanotechnology Education and Research Center at West Pomeranian University of Technology in Szczecin, Poland. Preliminary results showed biofilm reductions of 35% for S aureus and 42% for P aeruginosa. An optimized version of the phage-embedded bacterial cellulose dressing now reduces biofilm by 70% to 90% in vitro, Żywicka told Contagion.

Biofilms remain a major barrier in chronic wound treatment, since bacteria within them are often more tolerant of antibiotics and host immune defenses. S aureus, including methicillin-resistant S aureus (MRSA), and P aeruginosa are among the most common and problematic organisms in these wounds. Żywicka’s project is evaluating phages immobilized on a bacterial cellulose carrier for the treatment of wounds covered with biofilm.1

Bacterial cellulose is chemically identical to plant cellulose but is produced by nonpathogenic environmental bacteria, and its unique nanostructure gives it distinct properties. The material retains large amounts of moisture to keep the wound hydrated, does not adhere to the wound bed, and has a cooling effect which may reduce pain.It is also highly biocompatible, with no toxicity or strong immune reaction, making it suitable for direct wound contact.¹

The porous, three-dimensional nanostructure allows immobilization of bioactive substances, including bacteriophages, and supports diffusion of phages into the wound to attack bacteria. Since the preliminary analysis, the team has isolated additional phages, optimized the immobilization process, and assessed release efficiency. Żywicka selected the material as a phage carrier because of these combined properties.

Limitations of In Vitro Biofilm Data, Next Steps Toward Clinical Use

Żywicka cautioned against overinterpreting the in vitro findings. In real wounds, bacteria can survive, regrow, and develop resistance to bacteriophages, she noted. For this reason, clinical benefit will likely depend on combining phage therapy with other approaches, such as antibiotics or immune support.

In vitro biofilms are also typically simpler than those found in human wounds, which contain multiple species, host cells, proteins, and inflammatory factors. The next stage of the project will test the dressing against mixed-species biofilms and include molecular analyses to confirm safety.¹ Animal studies, and eventually clinical trials, would follow.

The broader project also aims to assess how free and immobilized phages affect human fibroblasts and macrophages, a key safety consideration for a dressing in sustained contact with wound tissue.1 The project will also evaluate how well the finished dressing works against biofilm-covered wounds.1

“Compared with simple liquid phage formulations, a bacterial cellulose membrane can protect phages from environmental stress, such as drying, and provide more controlled release of active phage over time,” Żywicka told Contagion.

Żywicka views the dressing as one part of a multimodal wound care approach for hard-to-treat infections. “I think bacterial cellulose dressing combined with bacteriophages could become an important precision antimicrobial strategy for chronic wounds, particularly those involving antibiotic-resistant and biofilm-forming bacteria, rather than replacing antibiotics completely,” she said.

Given the growing threat of antimicrobial resistance, Żywicka said phage-based approaches deserve serious consideration, despite the challenges still facing bacteriophage therapy.


References
  1. Żywicka A. The influence of free and immobilized bacteriophages on a bacterial cellulose-based carrier on human cells and the possibility of their application in the treatment of wounds covered with biofilm. National Science Centre, Poland. Accessed November 19, 2026. https://projekty.ncn.gov.pl/opisy/600949-en.pdf

Related to this article

The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.